Practice Based Nutrition Intervention

Practice-Based Nutrition Intervention

This study aims to test a dietary intervention for diabetes in a medical practice setting, with the aim of developing a model for diabetes care that can be used widely. The investigators hypothesize that a low-fat vegan diet will be effective for management of diabetes and will be feasible in a practice-based setting.

Study Overview

Status

Completed

Conditions

Detailed Description

Specific Aim 1 tests the hypothesis that the nutrition intervention (low fat, low-GI vegan diet) improves glycemic control, body weight, plasma lipid concentrations, blood pressure, and indices of renal function in a within-group analysis.

Specific Aim 2 tests the hypothesis that the nutrition intervention (low fat, low-GI vegan diet) is more effective than standard nutrition care for improving glycemic control, body weight, plasma lipid concentrations, blood pressure, and indices of renal function in individuals with type 2 diabetes

Specific Aim 3 tests the hypothesis that a low-fat vegan diet is sustainable among individuals with type 2 diabetes for a 20-week period, with weekly classes, and in a follow-up period of one year with limited professional support.

Specific Aim 4 tests the hypothesis that a low-fat vegan diet has an acceptability that is comparable to that of standard nutrition care among individuals with type 2 diabetes.

Specific Aim 5 tests the hypothesis that the effects of the dietary interventions on A1c and body weight are reduced in individuals with the A1 allele of the Taq1A and Taq1B polymorphism

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. a diagnosis of type 2 diabetes mellitus, as defined by a fasting plasma glucose concentration ≥126 mg/dl on 2 occasions or a prior physician's diagnosis of type 2 diabetes with the use of hypoglycemic medications for at least 6 months
  2. male or female
  3. A1c between 6.5% and 10.5%
  4. age at least 18 years
  5. ability and willingness to participate in all components of the study
  6. willingness to be assigned to either a low-fat, vegan diet or to standard nutrition care
  7. diabetes medications unchanged for 1 month prior to volunteering for the study
  8. patient of Dr. Mark Sklar

Exclusion Criteria:

  1. body mass index >45 kg/m2
  2. alcohol consumption of more than 2 drinks per day or the equivalent, episodic increased drinking (e.g., more than 2 drinks per day on weekends), or a history of alcohol abuse or dependency followed by any current use
  3. use of recreational drugs in the past 6 months (past drug use, if fully recovered, is not a criteria for exclusion)
  4. pregnancy or plans to become pregnant
  5. history of severe mental illness (with current unstable status)
  6. likely to be disruptive in group sessions (as determined by research staff)
  7. Signs/symptoms of acute uncontrolled diabetes (including but not limited to polyuria, polydipsia, blurred vision, uncontrolled weight loss)
  8. unstable medical status
  9. already following a low-fat, vegetarian diet
  10. an inordinate fear of blood draws
  11. inability to maintain current medication regimen
  12. lack of English fluency

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: diet following American Diabetes Association guidelines
Participants will follow diets based on ADA guidelines. This group will also receive weekly nutrition classes.
participants will be given instruction on the ADA guidelines for diabetes, and will follow an individualized plan based on these guidelines
Experimental: vegan diet
Participants in the intervention group will follow a low-fat, vegan diet for 20 weeks, and will attend nutrition classes in the form of a weekly support group.
Intervention group participants will follow a low-fat vegan diet and will receive instruction on this diet through the course of the study

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
hemoglobin A1C (diabetes management)
Time Frame: assessment at baseline (0 weeks)
assessment at baseline (0 weeks)
hemoglobin A1C (diabetes management)
Time Frame: assessment at 10 weeks
assessment at 10 weeks
hemoglobin A1C (diabetes management)
Time Frame: assessment at 20 weeks
assessment at 20 weeks
hemoglobin A1C (diabetes management)
Time Frame: assessment at one-year follow-up
assessment at one-year follow-up
lipid profile (serum cholesterol--total, LDL, HDL; triglycerides)
Time Frame: assessment at baseline (0 weeks)
assessment at baseline (0 weeks)
lipid profile (serum cholesterol--total, LDL, HDL; triglycerides)
Time Frame: assessment at 10 weeks
assessment at 10 weeks
lipid profile (serum cholesterol--total, LDL, HDL; triglycerides)
Time Frame: assesment at 20 weeks
assesment at 20 weeks
lipid profile (serum cholesterol--total, LDL, HDL; triglycerides)
Time Frame: assessment at one-year follow-up
assessment at one-year follow-up
body weight
Time Frame: assessment at baseline (0 weeks)
assessment at baseline (0 weeks)
body weight
Time Frame: assessment at 10 weeks
assessment at 10 weeks
body weight
Time Frame: assessment at 20 weeks
assessment at 20 weeks
body weight
Time Frame: assessment at one-year follow-up
assessment at one-year follow-up
indices of renal function (serum creatinine, microalbumin)
Time Frame: assessment at baseline (0 weeks)
assessment at baseline (0 weeks)
indices of renal function (serum creatinine, microalbumin)
Time Frame: assessment at 10 weeks
assessment at 10 weeks
indices of renal function (serum creatinine, microalbumin)
Time Frame: assessment at 20 weeks
assessment at 20 weeks
indices of renal function (serum creatinine, microalbumin)
Time Frame: assessment at one-year follow-up
assessment at one-year follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Neal D Barnard, MD, Washington Center for Clinical Research

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2010

Primary Completion (Actual)

June 1, 2011

Study Completion (Actual)

February 1, 2012

Study Registration Dates

First Submitted

October 12, 2010

First Submitted That Met QC Criteria

October 14, 2010

First Posted (Estimate)

October 18, 2010

Study Record Updates

Last Update Posted (Estimate)

August 7, 2012

Last Update Submitted That Met QC Criteria

August 6, 2012

Last Verified

August 1, 2012

More Information

Terms related to this study

Other Study ID Numbers

  • PBNI-1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type 2 Diabetes

Clinical Trials on diet following ADA guidelines

3
Subscribe